-
AI and IPF drug development
Very interesting recent article in Wired Magazine about AI enhanced drug development, including a little about a drug for IPF – ISM001-055 is for idiopathic pulmonary fibrosis, one of two new drugs where AI played a large role in getting it through a Phase 2 clinical trial. Hopefully this and other new drugs will continue to be advanced despite all the cutbacks to science funding. Here is the link https://www.wired.com/story/artificial-intelligence-drug-discovery/#:~:text=There%20are%20no%20drugs%20on,they're%20safe%20in%20patients.
wired.com
In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.